Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a magnetic mat ease bladder pain? small trial aims to find out

NCT ID NCT06013449

Symptom relief Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 16, 2026 · Updated 3 times

Summary

This study tests whether adding pulsed electromagnetic field (PEMF) therapy to standard bladder instillations of heparin and bupivacaine can better reduce chronic pelvic pain in women with interstitial cystitis/bladder pain syndrome. Twenty female adults who already receive bladder instillations will use a PEMF mat during treatment. Researchers will compare pain scores and symptom changes over six weeks to see if the combination is more effective than instillations alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pulsed electromagnetic field (PEMF) device plus bladder instillation of heparin and bupivacaine
What this could lead to
If it works, this could offer a new way to reduce chronic pelvic pain and improve quality of life for women with interstitial cystitis/bladder pain syndrome.
What could go wrong
This is a very small early study with only 20 participants, so results may not apply to everyone. The treatment is added to standard care, so any benefit beyond the usual instillation is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

May 2026

An estimate. Start dates often move.

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Previously established clinical diagnosis of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) * Current Numeric Rating Scale (NRS) greater than or equal to 5 * History of cystoscopy with hydrodistension with bladder capacity determination under anesthesia * No contraindications to the instillation solution * No cognitive deficits Exclusion Criteria: * History of bladder, ovarian or vaginal cancer * History of urethral diverticulum * History of radiation cystitis * History of spinal cord injury or spina bifida * History of Parkinson's Disease * History of Multiple Sclerosis (MS) * History of Stroke * History of genital herpes * History of or current cyclophosphamide treatment * Current placement of a pacemaker or metal prothesis * Active urinary tract infection * BMI \>40 * Residual urine of \>100 cc * Currently pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder pain syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

interstitial cystitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder pain syndrome Chronic interstitial cystitis Interstitial cystitis

More trials for these conditions

Other studies related to the condition(s) this trial covers.